Previous Article | Next Article 
Journal of Clinical Microbiology, April 2000, p. 1527-1535, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Development of Reverse Transcription-PCR Assays
Specific for Detection of Equine Encephalitis Viruses
Bettina
Linssen,1
Richard M.
Kinney,2
Patricia
Aguilar,3
Kevin L.
Russell,3
Douglas M.
Watts,3
Oskar-Rüger
Kaaden,1 and
Martin
Pfeffer1,*
Institute for Medical Microbiology,
Infectious and Epidemic Diseases, Ludwig-Maximilians University,
Munich, Germany,1 and Division of
Vector-Borne Infectious Diseases, National Center for Infectious
Diseases, Centers for Disease Control and Prevention, Public Health
Service, U.S. Department of Health and Services, Fort Collins,
Colorado,2 and Naval Medical
Research Center Detachment, NAMRID, Unit 3800 APO AA 34031, Peru3
Received 13 September 1999/Returned for modification 16 November
1999/Accepted 3 December 1999
 |
ABSTRACT |
Specific and sensitive reverse transcription-PCR (RT-PCR) assays
were developed for the detection of eastern, western, and Venezuelan
equine encephalitis viruses (EEE, WEE, and VEE, respectively). Tests
for specificity included all known alphavirus species. The EEE-specific
RT-PCR amplified a 464-bp region of the E2 gene exclusively from 10 different EEE strains from South and North America with a sensitivity
of about 3,000 RNA molecules. In a subsequent nested PCR, the
specificity was confirmed by the amplification of a 262-bp fragment,
increasing the sensitivity of this assay to approximately 30 RNA
molecules. The RT-PCR for WEE amplified a fragment of 354 bp from as
few as 2,000 RNA molecules. Babanki virus, as well as Mucambo and
Pixuna viruses (VEE subtypes IIIA and IV), were also amplified.
However, the latter viruses showed slightly smaller fragments of about
290 and 310 bp, respectively. A subsequent seminested PCR amplified a
195-bp fragment only from the 10 tested strains of WEE from North and
South America, rendering this assay virus specific and increasing its
sensitivity to approximately 20 RNA molecules. Because the 12 VEE
subtypes showed too much divergence in their 26S RNA nucleotide
sequences to detect all of them by the use of nondegenerate primers,
this assay was confined to the medically important and closely related
VEE subtypes IAB, IC, ID, IE, and II. The RT-PCR-seminested PCR
combination specifically amplified 342- and 194-bp fragments of the
region covering the 6K gene in VEE. The sensitivity was 20 RNA
molecules for subtype IAB virus and 70 RNA molecules for subtype IE
virus. In addition to the subtypes mentioned above, three of the
enzootic VEE (subtypes IIIB, IIIC, and IV) showed the specific amplicon
in the seminested PCR. The practicability of the latter assay was
tested with human sera gathered as part of the febrile illness
surveillance in the Amazon River Basin of Peru near the city of
Iquitos. All of the nine tested VEE-positive sera showed the expected
194-bp amplicon of the VEE-specific RT-PCR-seminested PCR.
 |
INTRODUCTION |
Venezuelan, eastern, and western
equine encephalitis viruses (VEE, EEE, and WEE, respectively) are
zoonotic viruses (genus Alphavirus, family
Togaviridae) transmitted to equides and humans by mosquitos.
They are maintained in enzootic transmission cycles by certain mosquito
species and in either rodents or birds which serve as natural hosts.
The ornithophilic mosquito Culiseta melanura transmits EEE
along the eastern coast of the United States, while Culex
species are involved in EEE transmission in Mexico, Central America,
and southward to Argentina (46, 50). The
less-host-restricted Aedes and Coquillettidia
species transmit EEE to humans and horses. While there is little
overlap between EEE and WEE in North America, both viruses are enzootic
in Central and South America. WEE cycles between passeriform birds and
Culex tarsalis, which also serves as the epizootic vector
(28).
VEE consist of related, but differentiable viruses that are classified
as a complex containing six antigenic subtypes (I to VI). Viruses of
subtypes I and III are further differentiated into five (IAB to IF) and
three (IIIA to IIIC) antigenic varieties, respectively (3, 4, 9,
15, 51). In contrast to both EEE and WEE, the distribution of VEE
is limited primarily to Central and South America. The two exceptions
are Everglades virus (EVE) found in Florida (6) and Bijou
Bridge virus (20) found in Colorado. EVE is antigenically
classified as a subtype II virus (51), but it is genetically
more closely related to the epizootic subtype IAB and IC viruses than
the VEE-IE virus strain Mena II (14, 48). Bijou Bridge virus
is genetically and antigenically classified as subtype IIIB virus
(20, 45). VEE epizootics, which were caused by subtype IAB
and IC viruses, frequently occurred in South America, including a 1969 to 1972 pandemic which spread from Central America to Texas in the
United States. After an absence of 20 years, epizootic VEE (subtype IC)
reemerged in Venezuela in 1993 (29). Since then, VEE has
caused concern because of (i) a large epizootic in Venezuela and
Colombia in 1995 involving about 75,000 humans and 50,000 equids
(30, 49), (ii) a small epidemic in Peru during 1994 caused
by a VEE-ID virus (23, 44), and (iii) two epidemics
affecting the southern Mexican horse population in 1993 and 1996 (22). Both outbreaks in Mexico were caused by VEE strains of
subtype-variety IE, thus far considered enzootic and not pathogenic for
horses (42).
The clinical signs of EEE-, WEE-, or VEE-infected humans and horses are
nonspecific, and a panel of nonviral and noninfectious etiologies has
to be considered (37). Although no specific treatment exists
for infections by these viruses, a fast and specific diagnosis is
needed to prevent the further spread of the disease by quarantine, trade restriction, vaccination, and vector control. Detection of the
viral antigen or its nucleic acid in serum is only successful if the
blood is collected during the viremic phase of the infection, which
lasts for 3 to 5 days. Virus isolation by intracerebral inoculation of
baby mice or cell cultures is the "gold standard" for virus
detection (24), but it is very time-consuming. RT-PCR is a
fast, sensitive, and specific alternative for the diagnosis of
infections caused by RNA viruses (26). This technique has been described for the detection of EEE (1, 40), WEE
(41), and VEE (2). In those studies, the
specificity of the RT-PCRs was not thoroughly tested. Recent work has
indicated that these assays failed to distinguish closely related
heterologous alphaviruses (19). The intent of the present
study was to provide specific diagnostic tests for each of the equine
encephalitis viruses, as verified by evaluating amplimer reactivities
with all known alphavirus species. Rapid diagnosis by sensitive,
virus-specific RT-PCRs would permit the timely implementation of
prevention and control measures. This is of particular importance in
countries such as Mexico, where all three equine encephalitis viruses
circulate simultaneously.
 |
MATERIALS AND METHODS |
Virus strains.
Each of the alphaviruses used in this
study represented one of the currently classified alphavirus species
(21). A description of the isolates, including the year and
location of isolation, as well as their passage history, was published
earlier (25). To evaluate each RT-PCR assay using a panel of
virus strains, nine additional virus isolates each of EEE and WEE were
chosen from the virus collection of the Division of Vector-Borne
Infectious Diseases, National Center for Infectious Diseases, Centers
for Disease Control, Fort Collins, Colo. The selection of isolates was
intended to include those with maximal geographical distribution (South
and North America) and various dates of virus isolation (Table
1). To further determine the specificity
or cross-reactivity of the RT-PCR, representative strains of the 12 VEE
subtypes were used as described earlier (14, 25). Recent VEE
isolates from Mexico and Peru were used as the original sera or their
first cell culture passage (Table 2).
Extraction of viral RNA.
Viral RNA was extracted from a
200-µl aliquot of infectious Vero cell culture supernatant according
to the method of Lewis et al. (18). The viral RNA was
rehydrated in 50 µl of diethyl pyrocarbonate (DEPC)-treated water
(25). The amount of RNA of each preparation was measured
photometrically (GeneQuant; Pharmacia), and the number of RNA molecules
was calculated on the basis of a genome length of 11,700 nucleotides
and an average weight for each nucleotide of 336.3 g/mol, yielding a
weight of 6.53 × 10
9 ng per RNA molecule.
Primer selection.
The oligonucleotide primers were chosen
from the aligned nucleotide sequences of the structural polyprotein
coding regions of Sindbis (38), Ockelbo (35),
Aura (31), Ross River (8), O'Nyong Nyong
(17), Chikungunya (M. Parker, GenBank accession no. L37661),
Semliki Forest (10), EEE (7, 46, 47, 50), WEE
(12), and representative strains of the VEE subtype viruses
(14). For each virus-specific detection, two primer pairs
each for primary RT-PCR and subsequent nested PCR were synthesized. Their sequences and genomic locations are presented in Table
3 and Fig.
1.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Oligonucleotide primers used for the specific
amplification of WEE, EEE, or VEE by RT-PCR and nested PCR
|
|

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic drawing of the alphavirus genome organization
(adapted from reference 39). The subgenomic 26S RNA
coding for the viral structural proteins is enlarged and has been drawn
to scale. The primers for the specific detection of each equine
encephalitis virus by RT-PCR or nested PCR are shown in boxes. Their
orientation is depicted by arrows and by their names (c, complementary
to the viral RNA, priming the RT). Each primer combination tested is
numbered in consecutive order. The letters following the roman numbers
indicate the type of reaction as follows: no letter, RT-PCR; n, nested
PCR; and sn, seminested PCR (see also Table 3). The size of each
amplicon is given in brackets.
|
|
General PCR procedures.
All RT-PCRs and nested PCRs were
carried out in 0.2 ml of thin-walled PCR tubes using a model 9600 or a
model 2400 thermocycler (Perkin-Elmer Corp.). The final reaction volume
was always 100 µl. During optimization of each of the specific RT-PCR
and nested-PCR assays, the amount of the following reagents was varied:
primers (0.1 to 1 µM, in 0.1 µM steps), MgCl2 (1 to 4 mM, in 0.5 mM steps), and deoxynucleoside triphosphate (dNTP) (100, 150, and 200 µM; MBI Fermentas). The remaining reagents were
identical in all RT-PCRs (5 mM dithiothreitol, 10 mM Tris-HCl (pH 8.3),
50 mM KCl, 0.01% gelatin, 2.5 U of TaqExtender PCR additive
(Stratagene, Heidelberg, Germany), 2 U of RAV-2 reverse transcriptase
(Amersham, Braunschweig, Germany), 2 U of AmpliTaq DNA
polymerase (Perkin-Elmer Corp., Weiterstadt, Germany), 5 µl of RNA
template, and DEPC-treated water to give a final volume of 100-µl).
Nested PCRs were performed in 100-µl reactions containing 10 mM
Tris-HCl (pH 8.3), 50 mM KCl, 0.01% gelatin, 5 mM dithiothreitol, 1.5 U of AmpliTaq DNA polymerase, and 2 µl of cDNA template
from the previous RT-PCR. The annealing temperatures tested in both
RT-PCRs and nested PCRs ranged from 55 to 72°C. For both RT-PCRs and
nested-PCRs, the optimal concentrations of MgCl2 and dNTP
were consistently 2 mM and 200 µM, respectively. Optimal results were
defined as the virus-specific amplification obtained with the primer
pairs, concentrations of reaction components, and cycling conditions
that allowed the most sensitive detection of the respective viral RNA.
When differing reactions resulted in the same sensitivity, criteria
such as the lack of signs of nonspecific background bands were used as
additional parameters to measure the success of the optimization.
To prevent carryover contaminations, pipetting of the reaction mixtures
for the RT-PCRs was performed under a hood in a room separated from
both the room where amplicons were analyzed by gel electrophoresis and
the room where the pipetting of the nested PCRs was done. A 10-µl
aliquot of each reaction was loaded onto 2% agarose gels (Eurogentec,
Heidelberg, Germany) in TBE buffer (0.1 M Tris-HCl, pH 8.0; 0.091 M
boric acid; 2 mM disodium EDTA). DNA fragments were visualized after
staining with ethidium bromide on a UV transilluminator at 302 nm
and recorded using a charge-coupled device CCD camera (Fröbel,
Wasserburg, Germany) and the FotoTouch Color software (Logitech).
All RT-PCR and nested-PCR were tested with genomic RNA template of
representative strains of all known alphavirus species to ensure virus
specificity within the genus.
EEE-specific RT-PCR and nested PCR.
Cycling conditions of
the uninterrupted RT-PCR program were 30 min at 50°C followed by one
cycle with denaturing at 94°C for 90 s, annealing at 64°C for
90 s, and extension at 72°C for 90 s and 35 cycles of
94°C for 20 s, 64°C for 30 s, and 72°C for 20 s.
The final extension step was prolonged to 5 min to ensure completion of
the length of the amplicon. Optimal results were obtained with 0.1 µM
concentrations each of primers EEE-4 and cEEE-7 (Table 3, combination II).
A 2-µl aliquot of the RT-PCR mixture was subjected to a nested PCR
which, after an initial denaturation at 94°C for 90 s, consisted
of 25 cycles of 94°C for 20 s, 65°C for 35 s, and 72°C for 17 s. The final elongation step was 4 min. EEE-5 and cEEE-6 primer concentrations of 0.3 µM each (combination IIn) yielded the
best results.
WEE-specific RT-PCR and seminested PCR.
For the specific
amplification of WEE, a set of three primers targeting the E2 gene and
implemented as RT-PCR and seminested PCR (Table 3, combinations I and
Isn) were found to be 300 times more sensitive than a RT-PCR-nested
PCR primer set (combinations II and IIn) hybridizing to the E2 and E1
genes embracing the 6K gene (Fig. 1; see also below). The reaction
conditions were as follows: 30 min at 50°C; one cycle consisting of
90 s at 94°C, 60 s at 68°C, and 90 s at 72°C; 35 cycles consisting of 20 s at 94°C, 30 s at 68°C, and
17 s at 72°C; and a final extension step of 5 min for the RT-PCR
I (Table 3). Each primer (WEE-1 and cWEE-3) was at 0.2 µM, while in
the subsequent seminested PCR (combination Isn) 0.3 µM concentrations
each of primers WEE-2 and cWEE-3 gave the best results. The cycling
conditions were as described for the EEE-specific nested PCR, except
that the annealing temperature was set at 63°C and the elongation
time was only 15 s.
VEE-specific RT-PCR and seminested PCR.
To develop
VEE-specific primers, the aligned 26S RNA sequence data of
representative strains of the 12 VEE subtype varieties were used
(14) and compared with the available sequence data of other
alphaviruses (see above). The level of nucleotide identity among VEE
subtype varieties IAB, IC, and ID was >94%, while this level dropped
to 70 to 88% when VEE-IAB was compared to the other subtype varieties
(14). To avoid the use of degenerate primers, we focused on
the genetically closely related and medically important VEE-IAB, -IC,
-ID, -II, and -IE subtype varieties. Unfortunately, highly homologous
regions among them also displayed a high level of nucleotide identity
to EEE or WEE in these regions. Hence, two forward and three reverse
primers were designed to function in RT-PCR-nested-PCR combinations
(Table 3, Fig. 1).
After we tested the specificity and sensitivity of each combination, we
found that performing the RT-PCR with primers VEE-2 versus cVEE-4
(Table 3, combination IV) with a seminested PCR using primers VEE-2
versus cVEE-3 (combination IIIsn) yielded the best results (see below).
The optimal reaction conditions were found to be an RT for 30 min at
50°C, followed by one cycle of 90 s at 94°C, 90 s at
61°C, and 90 s at 72°C and 35 cycles, each consisting of
20 s at 94°C, 40 s at 61°C, and 17 s at 72°C. The
final extension step was 5 min. For this RT-PCR (IV), 0.2 µM
concentrations of primers VEE-2 and cVEE-4 gave the best results. In
the subsequent seminested PCR (IIIsn), the cycling conditions were as
described for the WEE-specific seminested PCR (Isn), with VEE-2 and
cVEE-3 primer concentrations of 0.3 µM each found to give the best results.
Investigation of serum samples.
The VEE-specific RT-PCR
assay was applied to human sera gathered as part of the "febrile
illness surveillance in the Amazon River Basin." From all of the
serum samples listed in Table 2 virus was isolated in either Vero
cells, C6/36 cells, or newborn mice and subsequently identified as VEE
in an indirect immunofluorescence assay as described previously
(44). A Mayaro virus-positive serum sample served as a
negative control. RNA extracted from this serum was amplified by using
a genus-specific RT-PCR-seminested PCR as described earlier
(25). Compared to the VEE-specific RT-PCR-seminested PCR
method described above, the following slight modifications were made:
the viral RNA was extracted with the QIAmp viral RNA kit according to
the supplier's recommendation (Qiagen), no TaqExtender PCR
additive was used, SuperScript reverse transcriptase (2 U; Gibco BRL)
was used instead of RAV-2 reverse transcriptase, and the annealing
temperature was set at 55°C in the model 9600 thermocycler for both
RT-PCR and seminested PCR.
 |
RESULTS |
EEE-specific RT-PCR and nested PCR.
Based on the
nucleotide and the deduced amino acid sequence alignments of the
available alphaviral 26S RNA sequence data, a total of 10 regions with
virus-specific nucleotide sequences sufficiently distinct from the
remaining alphaviruses were identified. Primers for three regions
showed a high degree of self-complementarity and were not used. Of the
remaining seven regions, eight primers (one region was used for both a
forward and a reverse primer) were made, resulting in two sets of
RT-PCR-nested-PCR primer pairs. With the first RT-PCR (I in Table 3,
and Fig. 1) Aura virus yielded an amplicon of about 600 bp, which was
slightly smaller than the EEE-specific RT-PCR product of 635 bp (not
shown). In the subsequent nested PCR (In), the 10 tested EEE strains
exclusively yielded the expected 284-bp fragment rendering the I and In
combinations EEE specific. The sensitivity of this combination was
3 × 105 RNA molecules in the RT-PCR and 3 × 103 RNA molecules in the nested PCR (not shown). The second
set of primers for RT-PCR (II; EEE-4 versus cEEE-7) yielded the
expected 464-bp product with all of the EEE strains tested (Fig.
2A) and did not amplify the RNA of any
other alphavirus (not shown). Weak bands of 100 bp were visible for
most alphaviruses and the negative control, suggesting them to be of
primer dimer origin. In the respective nested PCR (IIn), the 262-bp
fragment was also only amplified with the EEE strains (Fig. 2B). None
of the other alphaviruses showed a visible amplicon (not shown). The
second combinations (II plus IIn) were 100-fold more sensitive than the
previous combination, detecting 3 × 103 (RT-PCR) and
30 RNA molecules (nested PCR), respectively (Fig. 2C).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 2.
Ethidium bromide-stained agarose gels showing the
results of EEE-specific amplification. A 10-µl aliquot of each
reaction was loaded onto 2% agarose gels. Amplicon sizes are depicted
in the margin. (A) Amplification of the EEE-specific 464-bp product
resulting from RT-PCR II of 10 different EEE strains (see Table 1) and
the closely related alphaviruses Buggy Creek (BCR) and Highlands J
(HJ), VEE-IAB strain Trinidad donkey (TRD), and WEE strain Fleming. The
negative control contained water instead of RNA in the reaction. (B)
The EEE-specific 262-bp amplification products resulting from nested
PCR IIn of the template cDNA derived from RT-PCR II (combinations II
plus IIn) shown in Fig. 2A. The negative control contained 2 µl of
the RT-PCR II negative control reaction. (C) Serial dilutions
containing 3 × 105 to 3 RNA molecules of EEE strain
NJ/60 used as template for EEE-specific RT-PCR II (left) and
subsequently performed nested-PCR IIn (right). The 262-bp amplification
product was visible on an ethidium bromide-stained agarose gel down to
the dilution containing 30 RNA molecules.
|
|
WEE-specific RT-PCR and seminested PCR.
Eleven regions with
sufficient sequence divergence compared to the other alphaviruses were
identified for WEE. Four possible primer sequences were excluded
because of predicted primer dimer formations. The remaining seven sites
were used to design primers for use in a RT-PCR-seminested PCR (Table
3, combinations I and Isn) and a RT-PCR-nested PCR (combinations II
and IIn) (Fig. 1). Testing of the specificity of the RT-PCR primers
revealed the expected 354-bp amplicon for all 10 WEE and slightly
smaller amplicons for Mucambo, Pixuna, and Babanki viruses for RT-PCR I
(Fig. 3A). The second primer pair (II)
amplified only the 10 WEE by RT-PCR (not shown). In the subsequently
performed seminested or nested round of amplification, either
combination (Isn or IIn) amplified the expected band (195 or 506 bp,
respectively) specifically for the 10 WEE strains tested (shown for Isn
in Fig. 3B). Although the first RT-PCR (I) was only WEE specific in
conjunction with the seminested PCR (Isn), it was found to be 300 times
more sensitive than the WEE-specific combinations II plus IIn. The
detection limits were 6 × 106 and 6 × 103 RNA molecules for combinations II plus IIn,
respectively. The RT-PCR of combination I detected 2 × 103 RNA molecules. This sensitivity was increased by a
factor of 100 in the seminested PCR (Isn), allowing the detection of as few as 20 RNA molecules (Fig. 4).

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 3.
Ethidium bromide-stained agarose gels showing the
results of WEE-specific amplification. A 10-µl aliquot of each
reaction was loaded onto 2% agarose gels. Amplicon sizes are depicted
in the margins. (A) Amplification of the WEE-specific 354-bp product
resulting from RT-PCR I of 10 different WEE strains (see Table 1) and
the closely related alphaviruses VEE-IAB strain Trinidad donkey (TRD),
VEE-IIIA strain Mucambo (MUC), VEE-IV strain Pixuna (PIX), EEE strain
NJ/60, Aura, Babanki (BBK), Buggy Creek (BCK), Highlands J (HJ), and
Fort Morgan (FM). The negative control contained water instead of RNA
in the reaction. While all 10 WEE strains showed the amplicon with the
expected size, MUC, PIX, and BBK showed a band smaller than 354 bp. (B)
The WEE-specific 195-bp amplification products resulting from
seminested PCR Isn of the amplicons derived from RT-PCR I shown in Fig.
3A (combinations I and Isn). The negative control contained 2 µl of
the RT-PCR I negative control reaction. In this subsequent reaction the
195-bp amplicon was visible only for the WEE strains, rendering the I
plus Isn combinations WEE specific.
|
|

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 4.
Serial dilutions containing 2 × 109 to
2 RNA molecules of WEE strain Fleming used as a template for
WEE-specific RT-PCR I (A) and subsequently performed seminested PCR Isn
(B). After RT-PCR, the expected 354-bp amplification product was
visible down to the reaction containing 2,000 RNA molecules (A). After
the subsequently performed seminested PCR Isn, the 195-bp amplicon was
visible on an ethidium bromide-stained agarose gel down to the dilution
containing 20 RNA molecules, enhancing the detection limit by a factor
of 100 (B).
|
|
VEE-specific RT-PCR and seminested PCR.
All five primer
combinations (Fig. 1) exclusively amplified VEE and no other alphavirus
when used in RT-PCRs (not shown). However, their reactivity with the
various VEE subtypes differed considerably. While all five RT-PCRs
amplified VEE-IAB, -IC, -ID, and -II equally well, RNA of VEE-IE strain
Mena II was amplified by RT-PCRs I and II to a much lower extent. None
of the five RT-PCRs amplified the RNA of VEE-IF strain 78V-3531. RT-PCR
I was the only RT-PCR that amplified the remaining VEE subtypes. RT-PCR II additionally amplified the three varieties of VEE subtype III (IIIA,
IIIB, and IIIC), while RT-PCR III additionally amplified RNA of
VEE-IIIB, -IIIC, and -IV. Only RT-PCRs IV and V reacted specifically
with the subtype viruses (VEE-IAB, -IC, -ID, -IE, and -II) that the
primers had been designed for (shown for RT-PCR IV in Fig.
5A). Smaller bands of lighter intensity
of about 100, 250, and 300 bp were produced with the other VEE subtypes
tested (Fig. 5A). Because detection of VEE-IE is important in light of the recent outbreaks in Mexico, RT-PCRs I and II were not chosen for
further testing. For a subsequent round of amplification, three
seminested PCRs using the templates from RT-PCR IV or V were possible,
i.e., IIIsn (194 bp) out of IV or V and IVsn (342 bp) out of V. Cross-reactivity among the VEE subtypes existed with the first
combinations (IV and IIIsn) for VEE-IIIB, -IIIC, and -IV (Fig. 5B),
which resembled the reaction pattern of RT-PCR III. In the combinations
V plus IIIsn, the 194-bp band was additionally produced for VEE
subtypes IIIB and IV, while the second combinations (V plus IVsn) did
not amplify RNA of VEE subtypes other than VEE-IAB to IE, and II (data
not shown). We determined the sensitivity of combinations IV plus IIIsn
and V plus IIIsn for both VEE-IAB strain Trinidad donkey (TRD) and for
VEE-IE strain Mena II. The sensitivity for VEE-IAB was the same for
both RT-PCR and seminested-PCR combinations, allowing the amplification
of 20 RNA molecules of strain TRD (shown for IV plus IIIsn in Fig. 5C).
For the amplification of VEE-IE strain Mena II, combinations IV plus
IIIsn detected 70 RNA molecules of VEE subtype variety IE. This was 10 times more sensitive than the V and IIIsn combinations with a detection limit of 700 RNA molecules.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 5.
Ethidium bromide-stained agarose gels showing the
results of VEE-specific amplification. A 10-µl aliquot of each
reaction was loaded onto 2% agarose gels. Amplicon sizes are depicted
in the margins. (A) Amplification of the VEE-specific 342-bp product
resulting from RT-PCR IV (see Table 3) of 12 VEE subtype varieties. The
negative control contained water instead of RNA in the reaction. Only
the VEE-IAB to -IE and the VEE-II strains showed the specific
amplification product. The remaining VEE subtypes displayed a weak band
ca. 100 bp shorter than that of the VEE subtypes above. (B)
VEE-specific amplification products of 194 bp resulting from seminested
PCR IIIsn of the amplicons derived from RT-PCR IV shown in Fig. 5A. The
negative control contained 2 µl of the RT-PCR IV negative control
reaction. Besides the VEE subtypes demonstrating a specific
amplification during RT-PCR IV, three VEE subtypes (IIIB, IIIC, and IV)
showed the specific 194-bp amplicon. (C) Serial dilutions containing
2 × 105 to 2 RNA molecules of VEE-IAB strain Trinidad
donkey (TRD) used as a template for VEE-specific RT-PCR IV (left) and
subsequently performed seminested PCR IIIsn (right). The 194-bp
amplification product was visible on an ethidium bromide-stained
agarose gel down to the dilution containing 20 RNA molecules of VEE-IAB
strain TRD.
|
|
VEE-specific combinations IV plus IIIsn were successfully applied to
serum samples known to be VEE positive by virus isolation. By using
RT-PCR IV, one serum sample (IQT 8131) showed the specific 342-bp
amplicon. All samples that were once passaged in cell cultures or
suckling mouse brain displayed the specific 342-bp band as well (Fig.
6A). After the subsequent seminested PCR
(IIIsn), all samples, including the serum samples that had been
negative after RT-PCR, showed the VEE-specific 194-bp amplicon (Fig.
6B).

View larger version (76K):
[in this window]
[in a new window]
|
FIG. 6.
Ethidium bromide-stained agarose gels showing the
results of VEE-specific amplification as applied to the VEE strains and
serum samples listed in Table 2. A 10-µl aliquot of each reaction was
loaded onto the 2% agarose gels. Amplicon sizes are depicted in the
margin. (A) Amplification of the VEE-specific 342-bp product resulting
from RT-PCR IV (see Table 3) was successful with RNA of all VEE
isolates from Peru and Mexico and with RNA of serum sample IQT 8131. The negative control contained RNA of a Mayaro virus-positive human
serum sample in the reaction. (B) In addition to the samples found to
be positive by RT-PCR alone, all samples showed the VEE-specific 194-bp
amplification products resulting from seminested PCR IIIsn of the
amplicons derived from RT-PCR IV shown in Fig. 6A. The negative control
contained 2 µl of the RT-PCR IV-negative control reaction.
|
|
 |
DISCUSSION |
The recent emergence and reemergence of equine
encephalitis viruses, in particular of VEE subtype varieties IC, ID,
and IE in Central and South America, is an important health concern
(22, 23, 29, 30, 44, 49). Because of the high epidemic
potential of these viruses, rapid confirmatory diagnosis is critical in order to quickly launch countermeasures such as quarantine,
vaccination, and mosquito control (37). High-titer viremias
in equine encephalitis virus-infected individuals are rather
short-lived, lasting only 3 to 5 days (36). Because these
alphaviruses are able to infect a variety of different hosts, there is
little to no growth restriction in the usual cell culture systems or
suckling mice, making virus isolation the "gold standard" for
antigen detection (24). However, virus isolation is
time-consuming and requires sterile handling of tissue cultures under
biosafety level 3 conditions. Further, crude mosquito extracts are
known to hamper virus isolation (33, 40, 41). In contrast,
molecular techniques such as the RT-PCR can yield results within 1 to 2 working days. RT-PCR has successfully amplified viral RNA from
EEE-infected mosquitos and bird tissues (1, 40) and
WEE-infected mosquitos (41). Recently performed evaluations
of the specificity of the latter two assays have revealed that they
also efficiently amplify other alphaviruses, i.e., Buggy Creek virus
and several subtypes of VEE (19). This is not surprising given the 50% or greater amino acid identities among the structural proteins of the three equine encephalitis viruses and the current lack
of sequence data for all known alphavirus species (39). Hence, the specificities of the assays presented here were tested with
representative strains of all 27 alphavirus species (21). To
further ascertain the specificity of an RT-PCR, subsequent reactions
with the amplicon, such as restriction enzyme digestion, hybridization
with specific DNA probes, or nested PCR should be performed (1,
25, 34, 41). We chose the latter option because a single
nucleotide substitution within the amplicon may affect the cleavage
site of a restriction enzyme but may not adversely affect hybridization
or nested-PCR priming. By using RT-PCR-nested-PCR combinations, we
rescued the specificities for EEE using combinations I plus In and for
WEE using combinations I plus Isn. Armstrong and coworkers
(1) achieved EEE specificity after dot hybridization with an
internal probe, whereas the corresponding amplicon of WEE did not
react. The EEE-specific assay described here was able to amplify the
RNA of two EEE isolates from Brazil. This is in contrast to the
EEE-specific assay described by Armstrong and coworkers, which failed
to detect the RNA of EEE strains from Panama and Brazil
(16). Because there was no heterologous amplification in the
subsequent nested PCRs, we did not investigate the origin of the
nonspecific Aura virus-derived amplicon in the EEE-specific RT-PCR I or
the reaction of the MUC, PIX, and BBK strains with WEE RT-PCR I. Amplicons that differ in size from the specific PCR product have been
observed with various bacterial DNAs or mosquito-borne flaviviral RNAs
in a recently described panel of VEE-specific RT-PCR assays
(2). Such circumstances require additional tests to confirm
the amplicon's origin. By using EEE combinations I plus In and WEE
combinations I plus Isn, we not only demonstrated virus specificity but
also enhanced the sensitivity 100-fold. This increase of the detection
limit corresponds to the findings of Sellner et al. (34) and
Hörling et al. (13), who published specific
RT-PCR-nested-PCR combinations for Ross River and Ockelbo viruses.
Applying the calculation that 3,000 RNA molecules are equal to 1.3 PFU
of Ross River virus (34) to the three equine encephalitis
viruses, the methods described here are likely to exceed the
sensitivity of enzyme immunoassay-based antigen detection procedures
(11, 32). The differences in the sensitivity of the
VEE-specific combinations IV plus IIIsn to detect IAB and IE subtype
varieties might be due to a mismatch of up to three nucleotides at the
5' end of each primer to the sequence of VEE-IE strain Mena II
(14). Interestingly, these differences are reflected by the
VEE subtype-specific reactivity of the primer pairs described by
Brightwell et al. (2). Based on their results, VEE-IF strain
78V-3531 reacted like VEE-VI strain Ag80-663. This further supports
recent studies suggesting that the antigenetically classified VEE-IF
strain is genetically closer related to VEE-VI (14, 27, 45).
Since our assay focused on VEE-IAB, -IC, -ID, and -II, the VEE-specific
combinations IV and IIIsn are most probably not suitable for the
screening of mosquito pools in enzootic foci because the enzootic VEE
subtypes are either not detected or are amplified with poor
sensitivity. However, the specific assays described here may be useful
in rapidly detecting and elucidating the occurrence, spread, and
epidemiology of the medically important equine encephalitis viruses.
Although it was only applied to a limited number of serum samples, the VEE-specific combinations IV plus IIIsn proved to be as sensitive as
virus isolation but were completed after 2 working days.
 |
ACKNOWLEDGMENTS |
We thank Grit Kermes for expert technical assistance. We are
indebted to Moises Fraire, Comision Mexico-Estados Unidos Para Aftosa,
and Rebeca Rico-Hesse, Southwest Foundation for Biomedical Research,
San Antonio, Tex., for providing the RNA of VEE-IE strain 142-96.
This work was supported by the Fraunhofer Gesellschaft (no.
2087-V-4390), Munich, Germany, and by the U.S. Naval Medical Research and Development Command NNMC, Bethesda, Md., work unit no. 62787A8701612.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute for
Medical Microbiology, Infectious and Epidemic Diseases,
Veterinaerstr. 13, D-80539 Munich, Germany. Phone: 49-89-2180-2593. Fax: 49-89-2180-2597. E-mail:
Martin.Pfeffer{at}micro.vetmed.uni-muenchen.de.
 |
REFERENCES |
| 1.
|
Armstrong, P.,
D. Borovsky,
R. E. Shope,
C. D. Morris,
C. J. Mitchell,
N. Karabatsos,
N. Komar, and A. Spielman.
1995.
Sensitive and specific colorimetric dot assay to detect eastern equine encephalomyelitis viral RNA in mosquitos (Diptera: Culicidae) after polymerase chain reaction amplification.
J. Med. Entomol.
32:42-52[Medline].
|
| 2.
|
Brightwell, G.,
J. M. Brown, and D. M. Coates.
1998.
Genetic targets for the detection and identification of Venezuelan equine encephalitis viruses.
Arch. Virol.
143:731-742[CrossRef][Medline].
|
| 3.
|
Calisher, C. H.,
N. Karabatsos,
J. S. Lazuick,
T. P. Monath, and K. L. Wolff.
1988.
Reevaluation of the western equine encephalitis antigenic complex of alphaviruses (family Togaviridae) as determined by neutralization tests.
Am. J. Trop. Med. Hyg.
38:447-452.
|
| 4.
|
Calisher, C. H.,
R. M. Kinney,
O. de Souza Lopes,
D. W. Trent,
T. P. Monath, and D. B. France.
1982.
Identification of a new Venezuelan equine encephalitis virus from Brazil.
Am. J. Trop. Med. Hyg.
31:1260-1272.
|
| 5.
|
Calisher, C. H.,
T. P. Monath,
M. S. Sabattini,
C. B. Cropp,
J. Kerschner,
A. R. Hunt, and J. S. Lazuick.
1985.
Arbovirus investigations in Argentinia, 1977-1980. III. Identification and characterization of viruses isolated, including new subtypes of western and Venezuelan equine encephalitis viruses and four new bunyaviruses (Las Malayos, Resistencia, Barranqueras, and Antequera).
Am. J. Trop. Med. Hyg.
34:956-965.
|
| 6.
|
Chamberlain, R. W.,
W. D. Sudia,
P. H. Coleman, and T. H. Work.
1964.
Venezuelan equine encephalitis virus from south Florida.
Science
145:272-274[Abstract/Free Full Text].
|
| 7.
|
Chang, G.-J. J., and D. W. Trent.
1987.
Nucleotide sequence of the genome region encoding the 26S mRNA of eastern equine encephalomyelitis virus and the deduced amino acid sequence of the viral structural proteins.
J. Gen. Virol.
68:2129-2142[Abstract/Free Full Text].
|
| 8.
|
Faragher, S. G.,
A. D. J. Meek,
C. M. Rice, and L. Dalgarno.
1988.
Genome sequences of a mouse-avirulent and a mouse-virulent strain of Ross River virus.
Virology
163:509-526[CrossRef][Medline].
|
| 9.
|
France, J. K.,
B. C. Wyrick, and D. W. Trent.
1979.
Biochemical and antigenic comparison of the envelope glycoproteins of Venezuelan equine encephalomyelitis strains.
J. Gen. Virol.
44:725-740[Abstract/Free Full Text].
|
| 10.
|
Garoff, H.,
A.-M. Frischauf,
K. Simons,
H. Lehrbach, and H. Delius.
1980.
Nucleotide sequence of cDNA coding for Semliki Forest virus membrane glycoproteins.
Nature (London)
288:236-241[CrossRef][Medline].
|
| 11.
|
Greiser-Wilke, I. M.,
V. Moennig,
O.-R. Kaaden, and R. E. Shope.
1991.
Detection of alphaviruses in a genus-specific antigen capture enzyme immunoassay using monoclonal antibodies.
J. Clin. Microbiol.
29:131-137[Abstract/Free Full Text].
|
| 12.
|
Hahn, C. S.,
S. Lustig,
E. G. Strauss, and J. H. Strauss.
1988.
Western equine encephalitis virus is a recombinant virus.
Proc. Natl. Acad. Sci. USA
85:5997-6001[Abstract/Free Full Text].
|
| 13.
|
Hörling, J.,
S. Vene,
C. Franzén, and B. Niklasson.
1993.
Detection of Ockelbo virus RNA in skin biopsies by polymerase chain reaction.
J. Clin. Microbiol.
31:2004-2009[Abstract/Free Full Text].
|
| 14.
|
Kinney, R. M.,
M. Pfeffer,
K. R. Tsuchiya,
G.-J. J. Chang, and J. T. Roehrig.
1998.
Nucleotide sequences of the 26S mRNAs of the viruses defining the Venezuelan equine encephalitis antigenic complex.
Am. J. Trop. Med. Hyg.
59:952-964[Abstract].
|
| 15.
|
Kinney, R. M.,
D. W. Trent, and J. K. France.
1983.
Comparative immunological and biochemical analyses of viruses in the Venezuelan equine encephalitis complex.
J. Gen. Virol.
64:135-147[Abstract/Free Full Text].
|
| 16.
|
Kuno, G.
1998.
Universal diagnostic RT-PCR protocol for arboviruses.
J. Virol. Methods
72:27-41[CrossRef][Medline].
|
| 17.
|
Levinson, R. S.,
J. H. Strauss, and E. G. Strauss.
1990.
Complete sequence of the genomic RNA of O'Nyong-Nyong virus and its use in the construction of alphavirus phylogenetic trees.
Virology
175:110-123[CrossRef][Medline].
|
| 18.
|
Lewis, J. G.,
G. J. Chang,
R. S. Lanciotti, and D. W. Trent.
1992.
Direct sequencing of large flavivirus PCR products for analysis of genome variation and molecular epidemiological investigations.
J. Virol. Methods
38:11-24[CrossRef][Medline].
|
| 19.
|
Linssen, B.,
R. M. Kinney,
O.-R. Kaaden, and M. Pfeffer.
1999.
In
U. Wernery, J. F. Wade, J. A. Mumford, and O.-R. Kaaden (ed.), Specific detection of equine encephalitis viruses by RT-PCR, p. 280-285.
Equine infectious diseases VIII. R & W Publications, Ltd., Newmarket, United Kingdom.
|
| 20.
|
Monath, T. P.,
J. S. Lazuick,
C. B. Cropp,
W. A. Rush,
C. H. Calisher,
R. M. Kinney,
D. W. Trent,
G. E. Kemp,
G. S. Bowen, and D. B. France.
1980.
Recovery of Tonate virus ("Bijou Bridge" strain), a member of the Venezuelan equine encephalomyelitis virus complex, from Cliff Swallow nest bugs (Oeciacus vicarium) and nestling birds in North America.
Am. J. Trop. Med. Hyg.
29:969-983.
|
| 21.
|
Murphy, F. A.,
C. M. Fauquet,
D. H. L. Bishop,
S. A. Ghabrial,
A. W. Jarvis,
G. P. Martelli,
M. A. Mayo, and M. D. Summers.
1995.
Virus taxonomy: classification and nomenclature of viruses. Sixth report of the International Committee on Taxonomy of Viruses.
In
Arch. Virol. Suppl. 10:428-433.
|
| 22.
|
Oberste, M. S.,
M. Fraire,
R. Navarro,
C. Zepeda,
M. L. Zarate,
G. V. Ludwig,
J. F. Kondig,
S. C. Weaver,
J. F. Smith, and R. Rico-Hesse.
1998.
Association of Venezuelan equine encephalitis virus subtype IE with two equine epizootics in Mexico.
Am. J. Trop. Med. Hyg.
59:100-107[Abstract].
|
| 23.
|
Oberste, M. S.,
S. C. Weaver,
D. M. Watts, and J. F. Smith.
1998.
Identification and genetic analysis of Panama-genotype Venezuelan equine encephalitis virus subtype ID in Peru.
Am. J. Trop. Med. Hyg.
58:41-46[Abstract].
|
| 24.
|
Office International des Epizooties.
1996.
Venezuelan equine encephalomyelitis, p. 452-456.
In
Manual of standards for diagnostic tests and vaccines. OIE Standards Commission (ed.), 3rd ed. OIE, Paris, France.
|
| 25.
|
Pfeffer, M.,
B. Proebster,
R. M. Kinney, and O.-R. Kaaden.
1997.
Genus-specific detection of alphaviruses by a semi-nested reverse transcription-polymerase chain reaction.
Am. J. Trop. Med. Hyg.
57:709-718.
|
| 26.
|
Pfeffer, M.,
M. Wiedmann, and C. A. Batt.
1995.
Applications of DNA amplification methods in veterinary diagnostics.
Vet. Res. Commun.
19:375-407[CrossRef][Medline].
|
| 27.
|
Powers, A. M.,
M. S. Oberste,
A. C. Brault,
R. Rico-Hesse,
S. M. Schmura,
J. F. F. Smith,
W. Kang,
W. P. Sweeney, and S. C. Weaver.
1997.
Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus.
J. Virol.
71:6697-6705[Abstract].
|
| 28.
|
Reisen, W. K., and T. P. Monath.
1988.
Western equine encephalomyelitis, p. 89-137.
In
T. P. Monath (ed.), The arboviruses: epidemiology and ecology, vol. V. CRC Press, Boca Raton, Fla.
|
| 29.
|
Rico-Hesse, R.,
S. C. Weaver,
J. De Singer,
G. Medina, and R. A. Salas.
1995.
Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America.
Proc. Natl. Acad. Sci. USA
92:5278-5281[Abstract/Free Full Text].
|
| 30.
|
Rivas, F.,
L. A. Diaz,
V. M. Cardenas,
E. Daza,
L. Bruzon,
A. Alcala,
O. de la Hoz,
F. M. Caceres,
G. Aristizabal,
J. W. Martinez,
D. Revelo,
F. de la Hoz,
J. Boshell,
T. Camacho,
L. Calderon,
V. A. Olano,
L. I. Villarreal,
D. Roselli,
G. Alvarez,
G. Ludwig, and T. Tsai.
1997.
Epidemic Venezuelan equine encephalitis in La Guarjira, Colombia, 1995.
J. Infect. Dis.
174:828-832.
|
| 31.
|
Rümenapf, T.,
E. G. Strauss, and J. H. Strauss.
1995.
Aura virus is a New World representative of Sindbis-like viruses.
Virology
208:621-633[CrossRef][Medline].
|
| 32.
|
Scott, T. W., and J. G. Olson.
1986.
Detection of eastern equine encephalomyelitis viral antigen in avian blood by enzyme immunoassay: a laboratory study.
Am. J. Trop. Med. Hyg.
35:611-618.
|
| 33.
|
Sellner, L. N.,
R. J. Coelen, and J. S. Mackenzie.
1992.
A one-tube, one manipulation RT-PCR reaction for detection of Ross River virus.
J. Virol. Methods
40:255-264[CrossRef][Medline].
|
| 34.
|
Sellner, L. N.,
R. J. Coelen, and J. S. Mackenzie.
1994.
Sensitive detection of Ross River virus a one tube nested RT-PCR.
J. Virol. Methods
49:47-58[CrossRef][Medline].
|
| 35.
|
Shirako, Y.,
B. Niklasson,
J. M. Dalrymple,
E. G. Strauss, and J. H. Strauss.
1991.
Structure of the Ockelbo virus genome and its relationship to other Sindbis viruses.
Virology
182:753-764[CrossRef][Medline].
|
| 36.
|
Shope, R. E.
1980.
Medical significance of togaviruses: an overview of the diseases caused by togaviruses in man and in domestic and wild vertebrate animals, p. 47-83.
In
R. W. Schlesinger (ed.), The togaviruses. Academic Press, New York, N. Y.
|
| 37.
|
Smith, J. F.,
K. Davis,
M. K. Hart,
G. V. Ludwig,
D. J. McClain,
M. D. Parker, and W. D. Pratt.
1997.
Viral encephalitides, p. 561-589.
In
R. Zajtchuk (ed.), Textbook of military medicine part I: warfare, weaponry, and the casualty. Medical aspects of chemical and biological warfare. Office of the Surgeon General, Department of the Army, Washington, D. C.
|
| 38.
|
Strauss, E. G.,
C. M. Rice, and J. H. Strauss.
1984.
Complete nucleotide sequence of the genomic RNA of Sindbis virus.
Virology
133:92-110[CrossRef][Medline].
|
| 39.
|
Strauss, J. H., and E. G. Strauss.
1994.
Alphaviruses.
Microbiol. Rev.
58:491-562[Abstract/Free Full Text].
|
| 40.
|
Vodkin, M. H.,
G. L. McLaughlin,
J. F. Day,
R. E. Shope, and R. J. Novak.
1993.
A rapid diagnostic assay for eastern equine encephalomyelitis viral RNA.
Am. J. Trop. Med. Hyg.
49:772-776.
|
| 41.
|
Vodkin, M. H.,
T. Streit,
C. J. Mitchell,
G. L. McLaughlin, and R. J. Novak.
1994.
PCR-based detection of arboviral RNA from mosquitos homogenized in detergent.
BioTechniques
17:114-116[Medline].
|
| 42.
|
Walton, T. E.,
O. Alvarez, Jr.,
R. M. Buckwalter, and K. M. Johnson.
1973.
Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus.
J. Infect. Dis.
128:272-282.
|
| 43.
|
Watts, D. M.,
J. Callahan,
C. Rossi,
M. S. Oberste,
J. T. Roehrig,
M. T. Wooster,
J. F. Smith,
C. B. Cropp,
E. M. Gentrau,
N. Karabatsos,
D. Gubler, and C. G. Hayes.
1998.
Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region.
Am. J. Trop. Med. Hyg.
58:35-40[Abstract].
|
| 44.
|
Watts, D. M.,
V. Lavera,
J. Callahan,
C. Rossi,
M. S. Oberste,
J. T. Roehrig,
C. B. Cropp,
N. Karabatsos,
J. F. Smith,
D. J. Gubler,
M. T. Wooster,
W. M. Nelson, and C. G. Hayes.
1997.
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru.
Am. J. Trop. Med. Hyg.
56:661-667.
|
| 45.
|
Weaver, S. C.,
L. A. Bellew, and R. Rico-Hesse.
1992.
Phylogenetic analysis of alphaviruses in the Venezuelan equine encephalitis complex and identification of epizootic viruses.
Virology
191:282-290[CrossRef][Medline].
|
| 46.
|
Weaver, S. C.,
A. Hagenbaugh,
L. A. Bellew,
L. Gousset,
V. Mallampalli,
J. J. Holland, and T. W. Scott.
1994.
Evolution of alphaviruses in the eastern equine encephalomyelitis complex.
J. Virol.
68:158-169[Abstract/Free Full Text].
|
| 47.
|
Weaver, S. C.,
A. Hagenbaugh,
L. A. Bellew,
S. V. Netesov,
V. E. Volchkov,
G.-J. J. Chang,
D. K. Clarke,
L. Gousset,
T. W. Scott,
D. W. Trent, and J. J. Holland.
1993.
A comparison of the nucleotide sequence of eastern and western equine encephalomyelitis viruses with those of other alphaviruses and related RNA viruses.
Virology
197:375-390[CrossRef][Medline].
|
| 48.
|
Weaver, S. C.,
W. Kang,
Y. Shirako,
T. Rümenapf,
E. G. Strauss, and J. H. Strauss.
1997.
Recombinational history and molecular evolution of western equine encephalomyelitis complex alphaviruses.
J. Virol.
71:613-623[Abstract].
|
| 49.
|
Weaver, S. C.,
R. Salas,
R. Rico-Hesse,
G. V. Ludwig,
M. S. Oberste,
J. Boshell, and R. B. Tesh for the VEE Study Group.
1996.
Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America.
Lancet
348:436-440[CrossRef][Medline].
|
| 50.
|
Weaver, S. C.,
T. W. Scott, and R. Rico-Hesse.
1991.
Molecular evolution of eastern equine encephalomyelitis virus in North America.
Virology
182:774-784[CrossRef][Medline].
|
| 51.
|
Young, N. A., and K. M. Johnson.
1969.
Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiologic significance.
Am. J. Epidemiol.
89:286-307[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, April 2000, p. 1527-1535, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
NI, H., YUN, N. E., ZACKS, M. A., WEAVER, S. C., TESH, R. B., DA ROSA, A. P. T., POWERS, A. M., FROLOV, I., PAESSLER, S.
(2007). RECOMBINANT ALPHAVIRUSES ARE SAFE AND USEFUL SEROLOGICAL DIAGNOSTIC TOOLS. Am J Trop Med Hyg
76: 774-781
[Abstract]
[Full Text]
-
Paessler, S., Ni, H., Petrakova, O., Fayzulin, R. Z., Yun, N., Anishchenko, M., Weaver, S. C., Frolov, I.
(2006). Replication and Clearance of Venezuelan Equine Encephalitis Virus from the Brains of Animals Vaccinated with Chimeric SIN/VEE Viruses. J. Virol.
80: 2784-2796
[Abstract]
[Full Text]
-
Bronzoni, R. V. d. M., Baleotti, F. G., Ribeiro Nogueira, R. M., Nunes, M., Moraes Figueiredo, L. T.
(2005). Duplex Reverse Transcription-PCR Followed by Nested PCR Assays for Detection and Identification of Brazilian Alphaviruses and Flaviviruses. J. Clin. Microbiol.
43: 696-702
[Abstract]
[Full Text]
-
Gardner, S. N., Kuczmarski, T. A., Vitalis, E. A., Slezak, T. R.
(2003). Limitations of TaqMan PCR for Detecting Divergent Viral Pathogens Illustrated by Hepatitis A, B, C, and E Viruses and Human Immunodeficiency Virus. J. Clin. Microbiol.
41: 2417-2427
[Abstract]
[Full Text]
-
SAHU, S. P., PEDERSEN, D. D., JENNY, A. L., SCHMITT, B. J., ALSTAD, A. D.
(2003). PATHOGENICITY OF A VENEZUELAN EQUINE ENCEPHALOMYELITIS SEROTYPE IE VIRUS ISOLATE FOR PONIES. Am J Trop Med Hyg
68: 485-494
[Abstract]
[Full Text]